pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Oncology · news · pharmadog
← back to Oncology
News · Oncology
928
stories
May 6, 26
Dr Pant on the Mechanism of Action of Daraxonrasib in PDAC
onclive
May 6, 26
Four-Year Follow-Up Outcomes in dMMR Endometrial Cancer Presented at SGO 2026
onclive
May 6, 26
CellCentric raises $220M for a ‘transformative’ multiple myeloma medicine
biopharma dive
May 6, 26
STAT+: Even at a meeting in Rome, FDA shifts are top of mind for gene therapy field
stat
May 5, 26
Dr Cohen on Frontline Chemotherapy Selection in Metastatic Pancreatic Cancer
onclive
May 5, 26
Dr Pant on Managing Toxicities With Daraxonrasib in PDAC
onclive
May 5, 26
Breast Cancer Experts Preview Abstracts to Watch at the 2026 ESMO Breast Cancer Congress
onclive
May 5, 26
The Type of Fat—Not the Amount—Fuels Pancreatic Cancer
onclive
May 5, 26
Second life for gene therapy; Takeda Phase 2/3 win; UK cancer biotech's $83M
endpoints
May 5, 26
Pfizer ends Trillium-related development as R&D spend jumps
endpoints
May 5, 26
Microbiome startup raises $48M for immunotherapy and malnutrition treatments
endpoints
May 5, 26
Dr McGregor on Key End Points of the STRIKE Trial of Tivozanib Plus Pembrolizumab in RCC
onclive
May 5, 26
Dr Kuykendall on the Evolving JAK Inhibitor and Transplant Considerations in Myelofibrosis
onclive
May 5, 26
New Endometrial Targets Beyond HER2
onclive
May 5, 26
Coordinating Care in Multiple Myeloma Across Practice Settings
onclive
May 5, 26
EGFR-Mutated NSCLC: Molecular Reassessment at Disease Progression
onclive
May 5, 26
Opinion: The ‘brain drain’ narrative about health professionals misses half of the story
stat
May 5, 26
Cytospire hauls in $83M for a new type of T cell engager
biopharma dive
May 4, 26
Celcuity strengthens case for ASCO-spotlighted breast cancer drug
biopharma dive
May 4, 26
Celcuity's breast cancer win; Odyssey plans $205M IPO
endpoints
May 4, 26
UCB to acquire maker of antibody treatments for autoimmune diseases
stat
May 4, 26
Federal court blocks mailing of mifepristone
stat
May 4, 26
UCB to acquire Candid in $2.2B bet on bispecifics for autoimmune diseases
biopharma dive
May 4, 26
What is your AI drug repurposing strategy missing?
biopharma dive
May 1, 26
Arvinas’ ‘Protac’ breast cancer drug cleared by FDA
biopharma dive
May 1, 26
FDA approves Pfizer and Arvinas' breast cancer drug despite underwhelming data
endpoints
May 1, 26
Summit’s ‘self-inflicted’ stumble; Esperion’s take-private deal
biopharma dive
May 1, 26
Moderna sees revenue bump from international COVID vaccine sales
biopharma dive
May 1, 26
Bristol Myers’ legacy lift, Biogen’s blue skies and Regeneron’s murky outlook
biopharma dive
May 1, 26
PFAS is still in some infant formula
stat
← prev
page 29 of 31
next →
